Several observations from preclinical and short-term clinical studies support a role for sildenafil in the treatment of heart failure patients. The following discussion briefly considers each of ...

Q4 2024 Management View CEO Sabrina Martucci Johnson announced the company's intent to make its proprietary Sildenafil Cream formulation available by prescription through a 503B-registered outsourcing ...

Viagra is a safe and effective treatment for ED. But as the saying goes, you can have too much of a good thing — and Viagra ...

Often referred to as the “little blue pill,” Viagra (which contains the active ingredient sildenafil) was first approved by the FDA as a treatment for ED in 1998 and quickly became one of the most ...

Thinking of increasing your sildenafil dosage on your own for even longer, harder arousal? Sorry to be a killjoy, but you ...

Erectile dysfunction (ED) is a common condition, and many people find that it is treatable with Viagra — sometimes called the “little blue pill” — and its generic form, sildenafil.

But a generic version (and the active ingredient) of this popular medication, sildenafil, is widely available from several drug manufacturers at a fraction of the cost. Here’s more about this ...

Objective: In view of the recent U.S. Food and Drug Administration's warning against the use of sildenafil in pediatric patients, we aimed to provide an updated overview of the dosing and safety ...

Dare Bioscience Inc (DARE) reports decreased expenses and secures significant funding, but faces ongoing financial hurdles ...

Dare’ Bioscience eported financial results for the year ended December 31 and provided a company update. “Dare exists to accelerate innovation ...

The company projects initial revenue generation from its Sildenafil Cream formulation in Q4 2025, backed by its 503B compounding strategy. Daré plans to provide updates in Q2 2025 on strategic ...